Molecular formula: | C22H28N6O8 |
Average mass: | 504.500 |
Monoisotopic mass: | 504.196862 |
ChemSpider ID: | 8350010 |
2 of 2 defined stereocentres
(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile citrate salt
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt)
[ACD/Index Name]2-Hydroxy-1,2,3-propantricarbonsäure --3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropannitril (1:1)
[German]
[ACD/IUPAC Name]2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
3-[(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile citrate salt
3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
[ACD/IUPAC Name]540737-29-9
[RN]Acide 2-hydroxy-1,2,3-propanetricarboxylique - 3-{(3R,4R)-4-méthyl-3-[méthyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-pipéridinyl}-3-oxopropanenitrile (1:1)
[French]
[ACD/IUPAC Name]CP 690,550
MFCD11616529
[MDL number]Tasocitinib citrate salt
Tofacitinib citrate
[USAN]1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ß-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
1259404-17-5
[RN]2-hydroxypropane-1,2,3-tricarboxylic acid and 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
3-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino) piperidin-1-yl)-3-oxopropanenitrile citric acid
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
540737-29-9 (citrate)
95%
CITRIC ACID; TOFACITINIB
CP-690550 (Tofacitinib citrate)
CP-690550 citrate
CP-690550 Citrate (Tofacitinib Citrate)
CP690550 citrate
MFCD23703608
[MDL number]O1FF4DIV0D
[UNII]racemic Tasocitinib
Tasocitinib citrate
Tasocitinib citrate;CP-690550 citrate;CP 690550 citrate;CP690550 citrate
Tasocitinib citric acid salt
Tofacitinib (citrate)
Tofacitinib (CP-690550) Citrate
Tofacitinib citrate (CP-690550 citrate)
TOFACITINIB CITRATE SALT
tofacitinib citrate(cp690550)
Xeljanz
[Trade name]